Chris Clark Email

Global Head Asset and Commercial Strategy, Rare Diseases . UCB

Current Roles

Employees:
15362
Revenue:
$3.1B
About
UCB aspires to be the patient-centric global biopharmaceutical leader, transforming the lives of people living with serious diseases. The company employs more than 8 000 people dedicated to the research, development and commercialisation of innovative medicines and patient solutions. Operating in more than 40 countries, UCB generated revenues of € 3.2 billion in 2011.
UCB Address
1950 Lake Park Drive
Smyrna, GA
United States

Past Companies

UCBGlobal Head of Asset and Commercial Strategy, Rare Diseases
UCB PharmaNew Journey Board Member
UCBGlobal Head, RoZi Mission

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.